These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35745798)

  • 1. Establishment of Level a In Vitro-In Vivo Correlation (IVIVC) via Extended DoE-IVIVC Model: A Donepezil Case Study.
    Lee DY; Shin S; Kim TH; Shin BS
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.
    Lim JY; Kim TH; Song CH; Kim DH; Shin BS; Shin S
    J Control Release; 2022 Mar; 343():443-456. PubMed ID: 35124130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically Relevant In Vitro-In Vivo Correlation (IVIVC) Approach for Sildenafil with Site-Dependent Dissolution.
    Kim TH; Shin S; Jeong SW; Lee JB; Shin BS
    Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31159390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Population Pharmacokinetics-Based in vitro-in vivo Correlation Model for Drugs with Site-Dependent Absorption: the Acyclovir Case Study.
    Shin S; Kim TH; Lee DY; Chung SE; Lee JB; Kim DH; Shin BS
    AAPS J; 2020 Jan; 22(2):27. PubMed ID: 31938935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of In Vitro-In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation.
    Mohamed MF; Trueman S; Othman AA; Han JH; Ju TR; Marroum P
    AAPS J; 2019 Oct; 21(6):108. PubMed ID: 31654328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel extended in vitro-in vivo correlation model for the development of extended-release formulations for baclofen: From formulation composition to in vivo pharmacokinetics.
    Kim TH; Bulitta JB; Kim DH; Shin S; Shin BS
    Int J Pharm; 2019 Feb; 556():276-286. PubMed ID: 30543888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of In Vitro-In Vivo Correlation for Potassium Chloride Extended Release Tablet Formulation Using Urinary Pharmacokinetic Data.
    Mittapalli RK; Marroum P; Qiu Y; Apfelbaum K; Xiong H
    Pharm Res; 2017 Jul; 34(7):1527-1533. PubMed ID: 28512718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.
    Yaro P; He X; Liu W; Xun M; Ma Y; Li Z; Shi X
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1670-6. PubMed ID: 24102615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, Physicochemical Characteristics and Pharmacokinetics of a New Sustained-Release Bilayer Tablet Formulation of Tramadol with an Immediate-Release Component for Twice-Daily Administration.
    Ishitsubo N; Oguro S; Shimahashi H; Kawanishi M; Adachi T; Mitsuda K; Ishibashi N
    Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):87-100. PubMed ID: 38064122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation.
    Mittapalli RK; Nuthalapati S; Delke DeBord AE; Xiong H
    Pharm Res; 2017 Jun; 34(6):1187-1192. PubMed ID: 28243955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro-In Vivo Correlation of Tianeptine Sodium Sustained-Release Dual-Layer Tablets.
    Lee YJ; Kim JE
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate.
    Kesisoglou F; Xia B; Agrawal NG
    AAPS J; 2015 Nov; 17(6):1492-500. PubMed ID: 26290380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Bioequivalent Extended-Release Formulations for Metformin by Principal Component Analysis and Convolution-Based IVIVC Approach.
    Zhang Y; Liu H; Tang MJ; Ho NJ; Shek TL; Yang Z; Zuo Z
    AAPS J; 2021 Mar; 23(2):38. PubMed ID: 33665728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers.
    Balan G; Timmins P; Greene DS; Marathe PH
    J Pharm Sci; 2001 Aug; 90(8):1176-85. PubMed ID: 11536222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and In Vitro-In Vivo Correlation Evaluation of IMM-H014 Extended-Release Tablets for the Treatment of Fatty Liver Disease.
    Zhang C; Shao H; Han Z; Liu B; Feng J; Zhang J; Zhang W; Zhang K; Yang Q; Wu S
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, Internal and External Validation of Naproxen Sodium Sustained Release Formulation: an Level A
    Narayanasamy R; Shabaraya R
    Turk J Pharm Sci; 2017 Aug; 14(2):120-126. PubMed ID: 32454602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of stereoselective pharmacokinetics in the development and predictability of an IVIVC for the enantiomers of metoprolol tartrate.
    Sirisuth N; Eddington ND
    Pharm Res; 2000 Aug; 17(8):1019-25. PubMed ID: 11028951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of In Vitro-In Vivo Correlation for Amorphous Solid Dispersion Immediate-Release Suvorexant Tablets and Application to Clinically Relevant Dissolution Specifications and In-Process Controls.
    Kesisoglou F; Hermans A; Neu C; Yee KL; Palcza J; Miller J
    J Pharm Sci; 2015 Sep; 104(9):2913-22. PubMed ID: 25611455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based in vitro - in vivo correlation of modified release oral formulations with non-linear intestinal absorption: A case study using mirabegron.
    Takahashi Y; Kambayashi A
    Eur J Pharm Biopharm; 2024 Nov; 204():114479. PubMed ID: 39233190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.